PURPOSE: To evaluate the feasibility of combining placement of a transjugular intrahepatic portosystemic shunt (TIPS) and transcatheter hepatic segmental artery chemoembolization with Lipiodol (Seg-Lp-TAE) in patients with cirrhosis, esophagogastric varices, and hepatocellular carcinoma (HCC). METHODS: Five patients with bleeding or large, high-flow esophagogastric varices and HCC were treated by TIPS and Seg-Lp-TAE. RESULTS: The mean portosystemic pressure gradient decreased from 20.8 cm H2O to 7.8 cm H2O after TIPS. The direct portogram and endoscopic examination revealed reduction of varices. At 6 months, one shunt had functionally occluded and could not be reopened; the other TIPS remained functional. Follow-up CT and the changes of alpha fetoprotein indicated effective therapy of Seg-Lp-TAE for HCC. Four patients are in stabile clinical condition at 9, 6, 1, and 1 months after the combined therapy; one died after 14 months due to decompensated liver cirrhosis. CONCLUSION: The combined therapy of TIPS and Seg-Lp-TAE will become a new interventional approach for patients with HCC and esophagogastric varices.
PURPOSE: To evaluate the feasibility of combining placement of a transjugular intrahepatic portosystemic shunt (TIPS) and transcatheter hepatic segmental artery chemoembolization with Lipiodol (Seg-Lp-TAE) in patients with cirrhosis, esophagogastric varices, and hepatocellular carcinoma (HCC). METHODS: Five patients with bleeding or large, high-flow esophagogastric varices and HCC were treated by TIPS and Seg-Lp-TAE. RESULTS: The mean portosystemic pressure gradient decreased from 20.8 cm H2Oto 7.8 cm H2O after TIPS. The direct portogram and endoscopic examination revealed reduction of varices. At 6 months, one shunt had functionally occluded and could not be reopened; the other TIPS remained functional. Follow-up CT and the changes of alpha fetoprotein indicated effective therapy of Seg-Lp-TAE for HCC. Four patients are in stabile clinical condition at 9, 6, 1, and 1 months after the combined therapy; one died after 14 months due to decompensated liver cirrhosis. CONCLUSION: The combined therapy of TIPS and Seg-Lp-TAE will become a new interventional approach for patients with HCC and esophagogastric varices.
Authors: Z J Haskal; E J Ring; J M LaBerge; M Y Peltzer; P M Radosevich; M M Doherty; R L Gordon Journal: Radiology Date: 1992-12 Impact factor: 11.105
Authors: J M Longo; J I Bilbao; H P Rousseau; L García-Villareal; J P Vinel; J M Zozaya; F G Joffre; J Prieto Journal: Radiology Date: 1993-02 Impact factor: 11.105
Authors: H Uchida; H Ohishi; N Matsuo; K Nishimine; S Ohue; Y Nishimura; M Maeda; T Yoshioka Journal: Cardiovasc Intervent Radiol Date: 1990 Jun-Jul Impact factor: 2.740
Authors: N Matsuo; H Uchida; K Nishimine; S Soda; M Oshima; H Nakano; N Nagano; Y Nishimura; T Yoshioka; Q Guo Journal: J Vasc Interv Radiol Date: 1993 Jul-Aug Impact factor: 3.464
Authors: G M Richter; G Noeldge; J C Palmaz; M Roessle; V Slegerstetter; M Franke; W Gerok; W Wenz; E Farthman Journal: Radiology Date: 1990-03 Impact factor: 11.105
Authors: P M Radosevich; E J Ring; J M LaBerge; M Y Peltzer; Z J Haskal; M M Doherty; R L Gordon Journal: Radiology Date: 1993-02 Impact factor: 11.105
Authors: John T Miura; William S Rilling; Sarah B White; Robert A Hieb; Sean M Tutton; Parag J Patel; T Clark Gamblin; Eric J Hohenwalter Journal: HPB (Oxford) Date: 2015-08 Impact factor: 3.647